Allmed Solutions Ltd

Tel Aviv Stock Exchange ALMD.TA

Allmed Solutions Ltd Revenue for the year ending December 31, 2023: USD 0.00

Allmed Solutions Ltd Revenue is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Allmed Solutions Ltd Revenue for the year ending December 31, 2022 was USD 0.00, a -100.00% change year over year.
Allmed Solutions Ltd Revenue for the year ending December 31, 2021 was USD 1.78 M, a -40.97% change year over year.
Allmed Solutions Ltd Revenue for the year ending December 31, 2020 was USD 3.02 M, a -6.18% change year over year.
Allmed Solutions Ltd Revenue for the year ending December 31, 2019 was USD 3.22 M, a 29.98% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Tel Aviv Stock Exchange: ALMD.TA

Allmed Solutions Ltd

CEO	Prof. Oz Shapira
IPO Date	Dec. 24, 2007
Location	Israel
Headquarters	2 Ha'Eshel Street
Employees	19
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.

Key trends

Past 5 years